Oasmia Pharmaceutical AB Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-08-21: Form 6-K; Period of report 2019-08-21; Description FORM 6-K; Document tv528008_6k.htm.
- 2019-08-15: Form 6-K; Period of report 2019-08-15; Description FORM 6-K; Document tv527729_6k.htm.
- 2019-08-06: Form 6-K; Period of report 2019-08-06; Description FORM 6-K; Document tv526667_6k.htm.
- 2019-08-01: Form 6-K; Period of report 2019-07-31; Description FORM 6-K; Document tv526427_6k.htm.